This inventor holds 1 USPTO granted patent. Top assignee: Rhone-Poulenc Sante. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: The Innovations of Serge Mondot
Introduction
Serge Mondot is a notable inventor based in Cagnes Sur Mer, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating coronary insufficiency. His work exemplifies the intersection of innovation and healthcare.
Latest Patents
Serge Mondot holds a patent for N-methyl-2-(3-pyridyl)-tetrahydrothio-pyran-2-carbothioamide 1-oxide. This patent focuses on the application of this compound, either as a racemic mixture of the 1S,2S and 1R,2R isomers or in the form of the 1R,2R isomer, for the preparation of medicinal products intended for the treatment of coronary insufficiency. This innovation highlights his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Mondot has been associated with Rhone-Poulenc Santé, a company known for its dedication to pharmaceutical research and development. His work there has allowed him to explore various avenues in medicinal chemistry, contributing to the advancement of healthcare solutions.
Collaborations
Serge Mondot has collaborated with Icilio A Cavero, enhancing the scope of his research and development efforts. Their partnership has likely fostered innovative approaches to medicinal chemistry.
Conclusion
Serge Mondot's contributions to the field of medicinal chemistry, particularly through his patent and work at Rhone-Poulenc Santé, underscore his role as an influential inventor. His dedication to developing treatments for coronary insufficiency reflects the importance of innovation in healthcare.